These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 29641905

  • 1. Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
    Mangadlao JD, Wang X, McCleese C, Escamilla M, Ramamurthy G, Wang Z, Govande M, Basilion JP, Burda C.
    ACS Nano; 2018 Apr 24; 12(4):3714-3725. PubMed ID: 29641905
    [Abstract] [Full Text] [Related]

  • 2. Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.
    Wang X, Tsui B, Ramamurthy G, Zhang P, Meyers J, Kenney ME, Kiechle J, Ponsky L, Basilion JP.
    Mol Cancer Ther; 2016 Aug 24; 15(8):1834-44. PubMed ID: 27297866
    [Abstract] [Full Text] [Related]

  • 3. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
    Dai L, Shen G, Wang Y, Yang P, Wang H, Liu Z.
    J Mater Chem B; 2021 Jan 28; 9(4):1151-1161. PubMed ID: 33434248
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen.
    Meher N, Seo K, Wang S, Bidkar AP, Fogarty M, Dhrona S, Huang X, Tang R, Blaha C, Evans MJ, Raleigh DR, Jun YW, VanBrocklin HF, Desai TA, Wilson DM, Ozawa T, Flavell RR.
    ACS Appl Mater Interfaces; 2021 Nov 24; 13(46):54739-54752. PubMed ID: 34752058
    [Abstract] [Full Text] [Related]

  • 5. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate Cancer Therapy.
    Hu J, Luo H, Qu Q, Liao X, Huang C, Chen J, Cai Z, Bao Y, Chen G, Li B, Cui W.
    ACS Appl Mater Interfaces; 2020 Sep 23; 12(38):42511-42520. PubMed ID: 32897691
    [Abstract] [Full Text] [Related]

  • 6. A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer.
    Wang X, Sun R, Wang J, Li J, Walker E, Shirke A, Ramamurthy G, Shan L, Luo D, Carmon L, Basilion JP.
    Theranostics; 2022 Sep 23; 12(5):2335-2350. PubMed ID: 35265213
    [Abstract] [Full Text] [Related]

  • 7. A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer.
    Shirke AA, Walker E, Chavali S, Ramamurthy G, Zhang L, Panigrahi A, Basilion JP, Wang X.
    Int J Mol Sci; 2024 Jun 28; 25(13):. PubMed ID: 39000194
    [Abstract] [Full Text] [Related]

  • 8. A PSMA-targeted theranostic agent for photodynamic therapy.
    Chen Y, Chatterjee S, Lisok A, Minn I, Pullambhatla M, Wharram B, Wang Y, Jin J, Bhujwalla ZM, Nimmagadda S, Mease RC, Pomper MG.
    J Photochem Photobiol B; 2017 Feb 28; 167():111-116. PubMed ID: 28063300
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of a photodynamic therapy agent using a canine prostate cancer model.
    Luo D, Wang X, Ramamurthy G, Walker E, Zhang L, Shirke A, Naidu NG, Burda C, Shakya R, Hostnik ET, Joseph M, Ponsky L, Ponomarev V, Rosol TJ, Tweedle MF, Basilion JP.
    Prostate; 2023 Sep 28; 83(12):1176-1185. PubMed ID: 37211857
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
    Lütje S, Heskamp S, Franssen GM, Frielink C, Kip A, Hekman M, Fracasso G, Colombatti M, Herrmann K, Boerman OC, Gotthardt M, Rijpkema M.
    Theranostics; 2019 Sep 28; 9(10):2924-2938. PubMed ID: 31244933
    [Abstract] [Full Text] [Related]

  • 11. Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors.
    Benešová M, Bauder-Wüst U, Schäfer M, Klika KD, Mier W, Haberkorn U, Kopka K, Eder M.
    J Med Chem; 2016 Mar 10; 59(5):1761-75. PubMed ID: 26878194
    [Abstract] [Full Text] [Related]

  • 12. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB, Johnson NR, Boya VKN, Chowdhury P, Othman SF, Khalilzad-Sharghi V, Hafeez BB, Ganju A, Khan S, Behrman SW, Zafar N, Chauhan SC, Jaggi M, Yallapu MM.
    Colloids Surf B Biointerfaces; 2016 Aug 01; 144():8-20. PubMed ID: 27058278
    [Abstract] [Full Text] [Related]

  • 13. Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?
    Luo D, Wang X, Zeng S, Ramamurthy G, Burda C, Basilion JP.
    Chem Sci; 2019 Sep 21; 10(35):8119-8128. PubMed ID: 31588336
    [Abstract] [Full Text] [Related]

  • 14. Targeted photodynamic therapy for prostate cancer: inducing apoptosis via activation of the caspase-8/-3 cascade pathway.
    Liu T, Wu LY, Choi JK, Berkman CE.
    Int J Oncol; 2010 Apr 21; 36(4):777-84. PubMed ID: 20198319
    [Abstract] [Full Text] [Related]

  • 15. Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors.
    Ngen EJ, Chen Y, Azad BB, Boinapally S, Jacob D, Lisok A, Shen C, Hossain MS, Jin J, Bhujwalla ZM, Pomper MG, Banerjee SR.
    Nanotheranostics; 2021 Apr 21; 5(2):182-196. PubMed ID: 33564617
    [Abstract] [Full Text] [Related]

  • 16. Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.
    Kasten BB, Liu T, Nedrow-Byers JR, Benny PD, Berkman CE.
    Bioorg Med Chem Lett; 2013 Jan 15; 23(2):565-8. PubMed ID: 23232055
    [Abstract] [Full Text] [Related]

  • 17. PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.
    Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG.
    Eur J Med Chem; 2022 Jan 05; 227():113936. PubMed ID: 34717125
    [Abstract] [Full Text] [Related]

  • 18. Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers.
    Zhao L, Kim TH, Kim HW, Ahn JC, Kim SY.
    Mater Sci Eng C Mater Biol Appl; 2016 Oct 01; 67():611-622. PubMed ID: 27287160
    [Abstract] [Full Text] [Related]

  • 19. PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer.
    Flores O, Santra S, Kaittanis C, Bassiouni R, Khaled AS, Khaled AR, Grimm J, Perez JM.
    Theranostics; 2017 Oct 01; 7(9):2477-2494. PubMed ID: 28744329
    [Abstract] [Full Text] [Related]

  • 20. In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.
    Liu T, Wu LY, Choi JK, Berkman CE.
    Prostate; 2009 May 01; 69(6):585-94. PubMed ID: 19142895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.